This, in line with previous observations made by us (24) and others (47) in the context of other hormone driven cancers, suggests that common genetic variants may modulate downstream effects of hormone signalling by altering the binding of hormone receptors or hormone regulated genes, potentially favouring the risk of developing cancer in only a subset of individuals carrying a specific genetic makeup. Here, NR4A1 is linked to cancer.